Patient Management in Clinical Trials
At Genelife Clinical Research, we recognize that patient recruitment and retention are the lifeblood of any successful clinical trial. Ensuring the timely enrollment and continued participation of patients is paramount to overcoming the challenges of drug development — a defining strength of our operations as a CRO in India.
Patient Recruitment Methodology
Patient-Centric Approach
Our commitment to patient-centricity goes beyond mere words — it is at the core of our clinical trial philosophy. We firmly believe that the patient experience profoundly influences trial outcomes.
Informed & Empowered Patients
Informed consent is not just a legal requirement — it is a moral imperative. We prioritize the consent process, ensuring every patient fully understands their participation, rights, and potential risks.
Building Strong Relationships
Genelife actively cultivates relationships with research organizations, academic institutions, hospitals, and medical professionals — creating a broad patient pool across therapeutic indications throughout India.
Disease Surveillance Reports
We utilize proprietary Disease Surveillance Reports to strategize patient recruitment based on therapeutic areas — enabling rapid identification and enrollment of suitable patients for each study.
Focus Groups & Community Engagement
We identify focus groups through comprehensive data resources and engage with disease communities, GPs, and independent disease surveys to access qualified patient populations.
Clear Exit Procedures
Patients are fully informed about procedures for leaving the study and the potential implications — maintaining full transparency about how their participation impacts study outcomes.
Patient Retention Strategies
- Transparent Communication: Clear understanding of the study, milestones, and the patient's vital role at every stage
- Accessible Support: Clear contact points for patients to address any questions — teams available at all times
- Safety First: Robust safety monitoring systems designed to swiftly detect and address any adverse events
- Recognition & Appreciation: Expressing appreciation for patients' critical contribution to advancing medical knowledge
- Minimizing Patient Burden: Efficient visit scheduling, clear communication, and reducing unnecessary procedures
- Continuous Interaction: Regular check-ins keeping patients engaged and connected throughout the study
Our Investigator Network in India
Genelife maintains a large, curated database of investigators across major hospitals, academic medical centers, and specialty clinics throughout India — providing access to diverse patient populations, experienced GCP-trained investigators, and geographic coverage across major Indian cities and tier-2 cities.
Patient Safety is Non-Negotiable: Every Genelife clinical trial incorporates robust pharmacovigilance and safety monitoring protocols — ensuring participant welfare is always the top priority throughout the study lifecycle.